4//SEC Filing
Palmer Pamela P 4
Accession 0001209191-23-047348
CIK 0001427925other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 4:45 PM ET
Size
6.8 KB
Accession
0001209191-23-047348
Insider Transaction Report
Form 4
Palmer Pamela P
DirectorChief Medical Officer
Transactions
- Sale
Common Stock
2023-08-24$1.17/sh−9,514$11,131→ 38,195 total - Sale
Common Stock
2023-08-25$1.09/sh−7,442$8,104→ 30,753 total
Footnotes (2)
- [F1]The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.17 to $1.19 on August 24, 2023. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares sold at each separate price.
- [F2]Balance includes non-reportable acquisition of 4,394 shares of Common Stock through the Company's Employee Stock Purchase Plan on February 28, 2023.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeother
Related Parties
1- filerCIK 0001511365
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 4:45 PM ET
- Size
- 6.8 KB